Safe Harbor Financial Rides Wave of Growth in Emerging US Cannabis Markets
Safe Harbor Financial reports a robust 29% year-over-year growth in emerging U.S. cannabis markets, driven by strategic early entry into key states and over 100 new customer accounts, signaling a…
Psychedelic and Cannabis Investment Convergence: R&D and Biotech Opportunities
The shift towards psychedelic research and therapy signals a more mature and specialized phase for alternative medicine investment. Companies with strong R&D, patent portfolios, and clinical…
ESG in Cannabis: Why Environmental and Social Practices Drive Investor Confidence
ESG is no longer just a buzzword; it\’s a fundamental pillar for investor scrutiny, and the cannabis industry is no exception. While cannabis has \’green\’ connotations, its environmental footprint…
Cannabis M&A Consolidation Wave: Opportunities and Risks in 2026
The cannabis industry is entering a new phase of consolidation, and M&A activity is heating up significantly in 2026. After years of rapid expansion, market saturation in key states and the push for…
How Technology Is Transforming Cannabis Operations and Consumer Experience
Beyond the plant itself, technology is rapidly reshaping the cannabis industry, driving efficiency, enhancing compliance, and revolutionizing the consumer experience. From AI-powered cultivation…
Cannabis Banking Breakthrough: Credit Unions Open Doors as Cash Dependency Fades
For over a decade, the cannabis industry has operated in a financial gray zone. Federal banking restrictions under the Controlled Substances Act have forced cannabis operators to operate largely in…
Curaleaf’s Cash Runway: The 18-Month Countdown
Curaleaf Holdings’ \$500M loan comes with a ticking clock. At current cash burn rates, the capital provides approximately 18-24 months of operational runway before the company faces a critical…
Don’t Even Think About Buying Canopy Growth Stock Unless…
This article highlights Canopy Growth’s significant decline, from a market leader to a penny stock, emphasizing the lack of profitability and ongoing financial struggles despite recent…
The Legalization Wildcard: Why 2026 Is Different This Time
If federal legalization passes in 2026, cannabis stocks could see a 30-50% rerating in 6 months. The market is pricing in ZERO probability. That’s the opportunity.
Organigram Announces Proposed Acquisition of Sanity Group, a Leading German Cannabis Company
Organigram’s acquisition of Sanity Group for up-front consideration of €113.4 million plus a maximum earnout of up to €113.8 million, positions it as a global pure-play cannabis company with…